Justin Averna, DO
Pain Medicine · Albuquerque, NMNPI 1518227131
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by SPR Therapeutics, Inc at 54.2% of the total. Reporting peaked in 2023 at $947 and has fallen 99.3% since, to $7 in 2024. That places this record below the midpoint for pain medicine clinicians in NM, where the typical reported total is $2,719.
Across 14 payments — averaging $107.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$814
- Electronic Waveform Lab, Inc.$354
- Nevro Corp.$284
- Abbott$38
- MDD US Operations, LLC$12
What the payments were for
- Travel & lodging$69246%
- Food & beverage$81054%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 2 | $814 |
| Electronic Waveform Lab, Inc. | 3 | $354 |
| Nevro Corp. | 6 | $284 |
| Abbott | 2 | $38 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$814
- Senza$107
- Omnia$106
How this compares
$1,502 in reported general payments places this provider in the 30th percentile of 36 pain medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 605 | $7,270 |
| Gabapentin | 87 | $1,151 |
| Buprenorphine Hcl | 24 | $510 |
| Tizanidine Hcl | 62 | $420 |
| Methylprednisolone | 18 | $146 |
| Meloxicam | 11 | $60 |
| Tramadol Hcl | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Albuquerque
- John WatkinsAlbuquerque$22K
- Craig RumbaughAlbuquerque$11K
- Eugene KoshkinAlbuquerque$10K
- Matthew BergstenAlbuquerque$7K
- Lauren HarrisAlbuquerque$6K
- Melissa MerhegeAlbuquerque$5K
- Jeremy ChastainAlbuquerque$5K
- Joshu RaitenAlbuquerque$4K
- Thomas WhalenAlbuquerque$4K
- Matthew ValerianoAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.